KINIKSA PHARMACEUTICALS (UK)

We understand there could be questions when starting or continuing a treatment, which is why the Kiniksa OneConnect™ program was created-to help make support simple. Once your doctor has prescribed ARCALYST and enrolled you in the Kiniksa OneConnect™ program, you will be paired with a dedicated Patient Access Lead (PAL) who will provide support and guidance throughout every step of treatment with ARCALYST... We offer personalized, one-on-one support to help you get the most from your experience with ARCALYST... Break free from future flares with ARCALYST® (rilonacept), the first and only FDA approved therapy for Recurrent Pericarditis.

Also known as: Kiniksa OneConnect, Kiniksa Pharmaceuticals, Kiniksa Pharmaceuticals (UK), Ltd.